Cargando…
Safety and cost-effectiveness of single dose dispensing of bevacizumab for various retinal pathologies in developing countries
Autores principales: | Velpandian, T, Sharma, C, Garg, SP, Mandal, S, Ghose, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635973/ https://www.ncbi.nlm.nih.gov/pubmed/17951922 |
Ejemplares similares
-
Costs and benefits of bevacizumab vial sharing for the treatment of retinal diseases
por: Sodré, Sávio Lima, et al.
Publicado: (2019) -
Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma
por: Mandal, Subrata, et al.
Publicado: (2011) -
Intravitreal bevacizumab in congenital retinal macrovessel with retinal arteriolar macroaneurysm
por: Goel, Neha, et al.
Publicado: (2015) -
Prescription Drug Costs and the Generic Dispensing Ratio
por: Liberman, Joshua N., et al.
Publicado: (2010) -
Retinal Angiomatous Proliferation and Intravitreal Bevacizumab Injection
por: Kang, Jae Hoon, et al.
Publicado: (2007)